LFST — LifeStance Health Group, Inc.

LifeStance Health Group, Inc. (LFST) 是一家 Medical - Care Facilities 公司，屬於醫療保健產業, 目前交易價格為 $6.51. 其SharesGrow評分為 59/100, 表明高於平均的投資特徵， 7項中通過2項.

SharesGrow calculates the intrinsic value of LFST = $346.59 (+5224% 相對於當前價格, 該股票看起來被低估). 分析師共識目標價為 LFST = $9 (+42.9% 上漲空間).

估值: LFST 本益比(P/E)為 259.5 (S&P 500平均約25) 前瞻PEG為 2.72.

財務數據: 營收為 $1.4B, +18.4%/yr 平均成長. 淨利潤為 $10M, 成長率為 +66.5%/yr. 淨利潤率為 0.7% (較薄). 毛利率為 28.5% (+0.9 pp 趨勢).

資產負債表: 總債務為 $194M 對比 $1.5B 股東權益 (D/E比率 0.13, 保守). 流動比率為 1.65 (流動性強). 資產負債率為 8.8%. 總資產: $2.2B.

分析師展望: 10 / 11 位分析師評級 LFST 為買入 (91%) — 強烈共識.

SharesGrow 7項標準細分: Value 51/100 (Partial), Growth 90/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 49/100 (Partial), Future 100/100 (Pass), Income 30/100 (Fail).

$9.30

▲ 42.86% 上漲空間

Average Price Target

基於 11 位華爾街分析師對 LifeStance Health Group, Inc. 提供的12個月價格目標，平均目標價為 $9.30，最高預測為 $11.00，最低預測為 $8.00。

Highest Price Target

$11.00

Average Price Target

$9.30

Lowest Price Target

$8.00

LFST SharesGrow 評分概覽

59/100

SharesGrow Score

Above average fundamentals

View full scorecard →

價值 51/100

估值 — P/E, PEG, Forward PEG

成長 90/100

財務數據 — 平均成長

過去 25/100

強勁 — 趨勢

健康 67/100

資產負債表 — D/E比率, 流動比率為

護城河 49/100

毛利率為 + market cap

未來 100/100

分析師展望 — 為買入

收入 30/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — LFST

~

價值 Partial

51/100

LFST 本益比(P/E)為 259.5 (S&P 500平均約25). Forward PEG 2.72 — 被高估. Trailing PEG 1.26. 分析師共識目標價為 $9, 意味著 +38.2% 相對於當前價格 $7. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

LFST: +18.4%/yr 營收為, +66.5%/yr 淨利潤為平均成長. > 5%/yr — 強勁. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

LFST: 1 / 4 年獲利. 較弱. Score = 1 / 4 × 100. ≥ 80 = Pass.

資產負債表 LFST: D/E比率 0.13 (保守), 流動比率為 1.65 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

LFST: 毛利率為 28.5% (+0.9 pp 趨勢), $3B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 49/100. ≥ 70 = Pass.

分析師展望: 10 / 11 位分析師評級 LFST 為買入 (91%). 分析師共識目標價為 $9 (+38.2% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

LFST: 淨利潤率為 0.7%. 較薄 (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間3.74-8.09

成交量1.28M

30日平均成交量2.21M

市值$2.54B

Beta（1年）1.13

Share Statistics

EPS（TTM）0.03

流通股數$386.02M

IPO Date2021-06-10

Employees7,535

CEODavid Patrick Bourdon

Financial Highlights & Ratios

Revenue (TTM)$1.42B

Gross Profit$406.35M

EBITDA$78.78M

Net Income$9.66M

Operating Income$25.71M

Total Cash$248.64M

Total Debt$194.1M

Net Debt$-54.55M

Total Assets$2.2B

Price / Earnings (P/E)217

Price / Sales (P/S)1.78

Analyst Forecast

1Y Price Target$9.00

Target High$11.00

Target Low$8.00

上漲空間+38.2%

評級共識Buy

覆蓋分析師數11

買入 91% 持有 9% 賣出 0%

Price Target Summary

公司資訊

國家US

交易所NASDAQ Global Select

貨幣USD

ISINUS53228F1012

股價走勢

LFST

LifeStance Health Group, Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Care Facilities

3.74 52WK RANGE 8.09

其他人也在看

UHS

Universal Health Services, Inc.

$181.95

-0.68%

ENSG

The Ensign Group, Inc.

$198.45

-0.92%

EHC

Encompass Health Corporation

$106.70

-0.80%

NHC

National HealthCare Corporation

$163.50

-3.60%

ACHC

Acadia Healthcare Company, Inc.

$26.56

+0.04%

SEM

Select Medical Holdings Corporation

$16.38

-0.06%

AMEH

Apollo Medical Holdings, Inc.

$40.82

-2.11%

ADUS

Addus HomeCare Corporation

$93.23

-1.96%

LifeStance Health Group, Inc. LFST NASDAQ

LFST SharesGrow 評分概覽

評分明細 — LFST

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒